Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing essential pharmaceutical ingredients that drive medical progress. Among these is Venetoclax (ABT-199), a vital component in the treatment of certain hematological cancers, particularly Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML).
Venetoclax functions as a selective inhibitor of the B-cell lymphoma 2 (Bcl-2) protein. This protein plays a critical role in regulating apoptosis, the natural process of programmed cell death. Cancer cells often exploit Bcl-2 to evade apoptosis, allowing them to survive and proliferate unchecked. By specifically targeting and binding to Bcl-2, Venetoclax disrupts this survival mechanism, thereby reinitiating apoptosis and leading to the elimination of cancer cells. This targeted mechanism is what sets it apart as a key innovation in cancer drug development.
The efficacy of Venetoclax has been well-established in the treatment of CLL. Patients often experience significant improvements when treated with this targeted therapy, which is administered orally. The drug's ability to selectively induce cancer cell death with potentially fewer side effects compared to traditional chemotherapy makes it a preferred treatment option for many.
For Acute Myeloid Leukemia (AML), Venetoclax is typically used in combination with other agents, such as azacitidine or decitabine, particularly for patients who are older or cannot tolerate standard chemotherapy. These combinations aim to enhance the overall therapeutic outcome by targeting different pathways or bolstering the immune response.
As a supplier of high-quality APIs, NINGBO INNO PHARMCHEM CO.,LTD. recognizes the importance of such advanced molecules in patient care. Understanding the Venetoclax mechanism of action and its precise role in targeting cancer cells is fundamental. The continued research and application of Venetoclax highlight the advancements in precision medicine and offer substantial hope for patients battling leukemia and other related cancers. For those seeking to purchase Venetoclax, quality and reliability are paramount, attributes that NINGBO INNO PHARMCHEM CO.,LTD. prioritizes.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
